• Chloroquine Pharmacogenomics: Evidence and Risk Phenotypes

  2026-09-24

  This systematic review brings together limited evidence that variants in CYP2C8, CYP3A5 and CYP2D6 may influence chloroquine and hydroxychloroquine safety or effectiveness. Its key contribution is a risk-phenotype framework that highlights potential variability across populations while underscoring the need for stronger clinical validation.

• TUDCA Workflows for ER Stress and Neuroprotection

  2026-09-24

  Tauroursodeoxycholic Acid (TUDCA) offers a practical way to test how ER stress, mitochondrial injury, and apoptosis contribute to cellular damage. This guide turns a subarachnoid hemorrhage study into a controlled assay workflow while distinguishing pathway-level evidence from TUDCA-specific conclusions.

• NF449 Dissects Platelet P2 Receptor Roles in Thrombosis

  2026-09-24

  Hechler and colleagues evaluated NF449 as a platelet P2X1 antagonist, showing that it inhibited P2X1 responses more potently than P2Y1 responses and had little effect on P2Y12 signaling in the assays tested. In mice, lower-dose treatment reduced platelet accumulation in thrombosis models without a statistically significant bleeding-time increase, whereas a higher dose inhibited all three platelet P2 receptors.

• Targeted PDT Needs Better Translational Proof

  2026-09-23

  How targeted photodynamic therapy research can move from impressive delivery results to rigorous, multimodal validation with fit-for-purpose fluorescence workflows.

• Axitinib Assay Workflows for VEGF Research

  2026-09-22

  Build more informative angiogenesis and cancer-response experiments with Axitinib (AG 013736), from VEGF pathway engagement to time-resolved viability and cell-death measurements. This workflow emphasizes practical dose design, solubility control, and the distinction between growth suppression and true cytotoxicity.

• Disodium Bicinchoninate in Redox Assays

  2026-09-22

  Disodium bicinchoninate is a water-compatible biochemical reagent whose value extends beyond simple protein quantification. This article connects its chemistry and handling requirements with assay-design lessons from a 2025 granulosa-cell inflammation study while clearly separating direct evidence from practical application.

• SB-505124 Hydrochloride and Cancer Cell Mechanics

  2026-09-21

  SB-505124 hydrochloride offers translational researchers a reversible way to interrogate ALK4/5/7-driven TGF-β and activin signaling alongside emerging models of cancer-cell mechanics. This article connects Smad pathway validation, fibrosis biology, formulation control, and AFM-based phenotyping while defining what the compound can—and cannot—establish about the MRTFA-KCNMB1 axis.

• PPP2R2A Loss Sensitizes HGSOC to CHK1 Inhibition

  2026-09-21

  The reference study identifies low PPP2R2A expression, encoding the PP2A B55α regulatory subunit, as a potential biomarker for sensitivity to CHK1 inhibition in high-grade serous ovarian cancer. Its experiments connect PPP2R2A deficiency with increased replication initiation, c-Myc-associated replication stress, and vulnerability that extends to models resistant to PARP inhibition.

• Oleanolic Acid: From iNOS Biology to Liposome Translation

  2026-09-20

  A translational perspective on how Oleanolic acid, inducible nitric oxide synthase induction, cyclooxygenase-2 modulation, and nanoparticle exclusion chromatography can be integrated into more rigorous antiviral and immune pathway research.

• MTT Cell Viability Assay: Workflow & Optimization

  2026-09-19

  MTT converts cellular redox activity into a practical colorimetric endpoint for proliferation, cytotoxicity, and host-cell safety studies. This guide shows how to optimize the assay and use it responsibly alongside antibacterial experiments such as plantaricin A and OP4 research.

• Prestained Protein Marker for SepM Assays

  2026-09-19

  Use this Triple color protein ladder to track broad-range separation, transfer efficiency, and protein-size confidence in SepM mutation workflows. Its EDTA-free formulation also supports Phosbind SDS-PAGE and fluorescent membrane imaging without heating or extra loading-buffer preparation.

• Chloroquine BA1002: Mechanisms and Research Uses

  2026-09-18

  Chloroquine is a 4-aminoquinoline and lysosomotropic compound used in malaria, autophagy, immunity, oncology, and antiviral research. Its cellular activity is experimentally broad, but in-vitro antiviral or anticancer results do not establish clinical efficacy or safe self-treatment.

• CFTRinh-172 in Precision CFTR Functional Assays

  2026-09-17

  CFTRinh-172 provides a rapid, reversible way to separate CFTR channel activity from CFTR trafficking in epithelial models. Its selectivity makes it especially useful for validating SHC-1-driven surface-abundance changes, cystic fibrosis research, and preclinical studies of secretory diarrhea.

• Imipenem Assay Design for Translational Research

  2026-09-17

  Imipenem is a semisynthetic thienamycin antibiotic with a distinctive PBP-targeting profile. This guide shows how to connect antibacterial, pharmacodynamic, immune-cell, and sepsis-model readouts into a more rigorous translational research workflow.

• SARS-CoV-2 N Protein Disrupts GADD34 Immunity

  2026-09-16

  This Molecules study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA in N+/G3BP1+ foci. The resulting loss of GADD34 impairs IRF3 nuclear localization and interferon production, providing a mechanistic explanation for viral suppression of innate immunity.

7986 records 1/533 page Next 12345 下5页 Last page